ABSCF Financial Statements From 2010 to 2025
| ABSCF Stock | USD 1.45 0.18 14.17% |
Check AB Science financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AB Science's main balance sheet or income statement drivers, such as , as well as many indicators such as . ABSCF financial statements analysis is a perfect complement when working with AB Science Valuation or Volatility modules.
ABSCF |
AB Science SA Company Shares Owned By Insiders Analysis
AB Science's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current AB Science Shares Owned By Insiders | 41.25 % |
Most of AB Science's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AB Science SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 41.25% of AB Science SA are shares owned by insiders. This is 171.74% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
AB Science SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AB Science's current stock value. Our valuation model uses many indicators to compare AB Science value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AB Science competition to find correlations between indicators driving AB Science's intrinsic value. More Info.AB Science SA is rated second in return on asset category among its peers. It also is rated second in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AB Science's earnings, one of the primary drivers of an investment's value.About AB Science Financial Statements
AB Science stakeholders use historical fundamental indicators, such as AB Science's revenue or net income, to determine how well the company is positioned to perform in the future. Although AB Science investors may analyze each financial statement separately, they are all interrelated. For example, changes in AB Science's assets and liabilities are reflected in the revenues and expenses on AB Science's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AB Science SA. Please read more on our technical analysis and fundamental analysis pages.
AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France. Ab Science operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 100 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in ABSCF Pink Sheet
AB Science financial ratios help investors to determine whether ABSCF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ABSCF with respect to the benefits of owning AB Science security.